Institutional investors hold a majority ownership of MYL through the 89.05% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended December 2013, these large investors purchased a net $8.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STRATEGIC ADVISERS, INC. Bought 225.8 Thousand shares of Mylan Inc
SIVIK GLOBAL HEALTHCARE LLC Bought 55.0 Thousand shares of Mylan Inc
BTR CAPITAL MANAGEMENT, INC. Bought 33.0 Thousand shares of Mylan Inc